GO:0051882 mitochondrial depolarization: Mitochondrial Quality Control Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051882 mitochondrial depolarization is the biological process in which the potential difference across the mitochondrial membrane is reduced from its steady state level.
• Loss of mitochondrial membrane potential is a decisive trigger for PINK1-PRKN/Parkin-dependent mitophagy, which clears damaged mitochondria.
• LRRK2 mutations impair depolarization-induced mitophagy by blocking mitochondrial accumulation of RAB10, linking this process to Parkinson disease biology.
• Mitochondrial depolarization can be reversible or terminal, as shown by depolarization and repolarization during acetaminophen hepatotoxicity.
• High-frequency nanosecond and microsecond electroporation can induce mitochondrial depolarization and ATP loss, making it a measurable bioelectrochemical endpoint.
• Depolarization promotes calcium alternans in ventricular myocyte models, connecting mitochondrial energetics to cardiac electrical instability.
Description
Mitochondrial depolarization (GO:0051882) is the process in which the potential difference across the mitochondrial membrane is reduced from its steady state level. This membrane potential, commonly called delta-psi-m, is generated by proton pumping across the inner mitochondrial membrane and is central to ATP synthesis, ion homeostasis, and mitochondrial quality control. When the potential collapses, the organelle can either recover or be committed to degradation and removal. Because depolarization sits at the intersection of energy metabolism, cell death, and autophagy, it is a high-value phenotype for researchers in neurodegeneration, hepatotoxicity, cardiology, and mitochondrial disease. In this article, we define GO:0051882, describe the molecular events that accompany loss of membrane potential, list the key genes and proteins that regulate it, and outline CRISPR-based models and methods used to study it.
mitochondrial depolarization At A Glance
| GO ID | GO:0051882 |
|---|---|
| GO term | mitochondrial depolarization |
| Ontology | biological_process |
| Synonym | mitochondria depolarization; mitochondrial depolarisation; mitochondrial membrane depolarization; mitochondrion depolarization |
| Major function | Reduction of the mitochondrial membrane potential from its steady state, triggering downstream quality control, metabolic, and cell death responses |
| Related process | PINK1-PRKN/Parkin-dependent mitophagy and mitochondrial quality control |
| Key regulator examples | PINK1, PRKN/Parkin, PHB2, RAB10, LRRK2, USP33 |
| Measurable readouts | Mitochondrial membrane potential dyes, ATP loss, mitophagic engulfment by cryo-ET |
What Is GO:0051882?
In our own words, mitochondrial depolarization is the reduction of the electrical potential difference across the mitochondrial membrane from its normal resting level. The QuickGO definition states that it is the process in which the potential difference across the mitochondrial membrane is reduced from its steady state level. This can occur as a transient, reversible drop or as a sustained collapse that signals organelle damage. It is a biological process rather than a single molecular activity, and it is often measured with potentiometric dyes or electrophysiological readouts.
Why Is mitochondrial depolarization Important in Cell Biology?
Mitochondrial depolarization is important because it is one of the earliest and most informative signals of mitochondrial dysfunction. It determines whether a damaged mitochondrion is repaired, repolarized, or targeted for autophagic removal. Defects in depolarization-induced mitophagy are linked to Parkinson disease through LRRK2 and PRKN pathways. In the liver, depolarization and repolarization kinetics distinguish reversible from irreversible acetaminophen injury. In the heart, depolarization promotes calcium alternans and electrical instability. Therefore, measuring and manipulating GO:0051882 is essential for mechanistic studies of neurodegeneration, drug toxicity, and cardiac arrhythmia.
• It is a primary trigger for PINK1-PRKN/Parkin-dependent mitophagy, a major mitochondrial quality control pathway.
• LRRK2 mutations impair depolarization-induced mitophagy through failed mitochondrial RAB10 accumulation, linking GO:0051882 to Parkinson disease.
• PHB2 promotes PINK1-PRKN/Parkin-dependent mitophagy via the PARL-PGAM5-PINK1 axis, connecting inner membrane proteins to depolarization signaling.
• USP33 deubiquitinates PRKN/parkin and antagonizes its role in mitophagy, showing that depolarization responses are enzymatically reversible.
• Acetaminophen hepatotoxicity involves early mitochondrial depolarization and repolarization, making it a model for reversible versus irreversible injury.
• High-frequency nanosecond and microsecond electroporation cause mitochondrial depolarization and ATP loss, relevant to electroporation-based therapies.
• Mitochondrial depolarization promotes calcium alternans in ventricular myocytes, linking energetics to arrhythmogenesis.
• Alternative mitochondrial quality control can occur through extracellular release, expanding the fate options after depolarization.
• In situ cryo-ET can visualize depolarization and mitophagic engulfment, providing structural evidence for the process.
What Happens During mitochondrial depolarization?
Initiation: loss of membrane potential
In simple terms: The mitochondrion loses its electrical charge across the inner membrane.
Mitochondrial depolarization begins when the potential difference across the mitochondrial membrane is reduced from its steady state level. This can be triggered by protonophore uncoupling, respiratory chain inhibition, calcium overload, or electroporation. In acetaminophen hepatotoxicity, early depolarization can be followed by repolarization, indicating that the process is not always terminal. The initial drop in membrane potential is the defining event of GO:0051882.
Sensing and PINK1 stabilization
In simple terms: The cell detects the lost charge and stabilizes a sensor protein on the damaged mitochondrion.
Loss of membrane potential stabilizes PINK1 on the outer mitochondrial membrane, which is a key step for downstream mitophagy. PHB2 promotes PINK1-PRKN/Parkin-dependent mitophagy through the PARL-PGAM5-PINK1 axis, linking inner membrane depolarization to the sensing machinery. This sensing step converts a biophysical change into a biochemical signal.
PRKN/Parkin activation and ubiquitination
In simple terms: A ubiquitin ligase is recruited and tags mitochondrial proteins for removal.
PINK1 recruits and activates PRKN/Parkin, which ubiquitinates outer mitochondrial membrane proteins to mark the organelle for autophagic degradation. USP33 deubiquitinates PRKN/parkin and antagonizes its role in mitophagy, providing a counter-regulatory mechanism. This ubiquitin code is essential for selective removal of depolarized mitochondria.
RAB10 accumulation and mitophagy
In simple terms: A small GTPase helps build the autophagic membrane around the damaged mitochondrion.
Depolarization-induced mitophagy requires mitochondrial accumulation of RAB10, and LRRK2 mutations impair this step. This links GO:0051882 to Parkinson disease-associated genes. In situ cryo-ET has visualized mitophagic engulfment after depolarization, confirming the structural outcome.
Alternative outcomes: repolarization or extracellular release
In simple terms: The mitochondrion may recover, be degraded, or be released from the cell.
Not all depolarized mitochondria are degraded. In acetaminophen hepatotoxicity, depolarization can be followed by repolarization, indicating recovery. Alternative mitochondrial quality control can also occur through extracellular release. These outcomes show that GO:0051882 is a branch point in mitochondrial fate.
Key Genes Involved in GO:0051882 mitochondrial depolarization
The following genes and proteins are experimentally implicated in mitochondrial depolarization, its sensing, and its downstream quality control responses.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PINK1 | Stabilized on depolarized mitochondria; initiates mitophagy | Core sensor of GO:0051882; Parkinson disease gene |
| PRKN | Parkin E3 ubiquitin ligase; ubiquitinates outer membrane proteins | Effector of depolarization-induced mitophagy |
| PHB2 | Prohibitin 2; promotes PINK1-PRKN/Parkin-dependent mitophagy via PARL-PGAM5-PINK1 axis | Links inner membrane to depolarization signaling |
| RAB10 | Small GTPase; accumulates on mitochondria during depolarization-induced mitophagy | LRRK2 mutation impairs its mitochondrial accumulation |
| LRRK2 | Kinase; regulates RAB10 accumulation and mitophagy | Parkinson disease mutations impair depolarization-induced mitophagy |
| USP33 | Deubiquitinase; removes ubiquitin from PRKN/parkin | Antagonizes mitophagy after depolarization |
| PARL | Inner membrane protease; processes PGAM5 and PINK1 | Part of PHB2-PARL-PGAM5-PINK1 axis |
| PGAM5 | Mitochondrial phosphatase; involved in PINK1 stabilization | Component of depolarization sensing |
| ATP synthase subunits | Generate and maintain membrane potential | Loss of potential affects ATP production |
| Voltage-dependent anion channels | Outer membrane permeability | Contribute to membrane potential and depolarization |
| Calcium channels | Mitochondrial calcium uptake | Calcium overload can trigger depolarization |
| Mitophagy receptors | Recognize ubiquitinated mitochondria | Execute removal after depolarization |
| Autophagy machinery | Forms autophagosomes around damaged mitochondria | Required for mitophagic engulfment |
| Electron transport chain complexes | Proton pumping maintains membrane potential | Inhibition causes depolarization |
| Uncoupling proteins | Dissipate proton gradient | Can induce depolarization |
| BCL2 family proteins | Regulate outer membrane permeabilization | May interact with depolarization in cell death |
How Is mitochondrial depolarization Regulated?
Mitochondrial depolarization is regulated by the balance between proton pumping by the electron transport chain and proton leak or uncoupling. PINK1 stabilization and PRKN/Parkin activation provide a quality control feedback loop that removes persistently depolarized mitochondria. LRRK2 modulates this process by controlling mitochondrial RAB10 accumulation, and disease mutations in LRRK2 impair depolarization-induced mitophagy. USP33 deubiquitinates PRKN/parkin, acting as a negative regulator of mitophagy after depolarization. PHB2, PARL, PGAM5, and PINK1 form an axis that couples inner membrane status to mitophagic commitment. In excitable cells, calcium handling and electrical activity can also influence depolarization dynamics, as shown by calcium alternans in ventricular myocyte models.
mitochondrial depolarization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LRRK2 | Parkinson disease; impaired depolarization-induced mitophagy | LRRK2 mutant knock-in cell model |
| PRKN | Parkinson disease; defective mitophagy | PRKN knockout cell line |
| PINK1 | Parkinson disease; failed depolarization sensing | PINK1 knockout cell line |
| PHB2 | Mitophagy regulation; inner membrane signaling | PHB2 knockout or overexpression |
| USP33 | Mitophagy antagonism; Parkinson disease modifier | USP33 knockout or overexpression |
Parkinson disease and neurodegeneration
LRRK2 mutations impair depolarization-induced mitophagy through inhibition of mitochondrial accumulation of RAB10, directly linking GO:0051882 to Parkinson disease pathogenesis. PRKN/Parkin and PINK1 are established Parkinson disease genes, and their function in depolarization-induced mitophagy is central to neuronal mitochondrial quality control. USP33 deubiquitinates PRKN/parkin and antagonizes mitophagy, further tuning this pathway.
Drug-induced liver injury
In acetaminophen hepatotoxicity, mitochondrial depolarization and repolarization occur in early stages, and the kinetics of these changes distinguish reversible from irreversible injury. This makes GO:0051882 a mechanistic biomarker for hepatotoxicity research.
Cardiac arrhythmia and calcium alternans
Mitochondrial depolarization promotes calcium alternans in ventricular myocyte models, providing mechanistic insight into how mitochondrial energetics influence cardiac electrical stability. This connects GO:0051882 to arrhythmogenesis.
Electroporation-based therapies
High-frequency nanosecond and microsecond electroporation induce mitochondrial depolarization and ATP loss, which is relevant to the safety and efficacy of electroporation-based treatments.
From mitochondrial depolarization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate depolarization-induced mitophagy? | Knockout cell line with mitochondrial potential dye and mitophagy flux assay |
| Does a disease mutation alter depolarization kinetics? | Point-mutation knock-in of LRRK2 or PRKN |
| Where does a protein localize after depolarization? | Tagged knock-in with fluorescent reporter |
| Can overexpression rescue depolarization-induced mitophagy? | Overexpression cell model |
| Does depolarization cause ATP loss? | Knockout or wild-type cells with ATP luminescence assay |
| Does depolarization promote calcium alternans? | Ventricular myocyte model with computational simulation |
How to Study the mitochondrial depolarization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| TMRM or JC-1 imaging | Mitochondrial membrane potential | Live-cell depolarization assays |
| In situ cryo-ET | Structural visualization of depolarization and mitophagic engulfment | High-resolution mitophagy studies |
| Mitophagy flux assay | Degradation of mitochondrial proteins | PINK1-PRKN-dependent mitophagy |
| ATP luminescence | Cellular ATP levels | Electroporation-induced ATP loss |
| Seahorse respirometry | Oxygen consumption rate | Mitochondrial function after depolarization |
| Calcium imaging | Cytosolic calcium transients | Calcium alternans in cardiomyocytes |
| Computational modeling | Simulated membrane potential and calcium dynamics | Cardiac arrhythmia mechanisms |
| Ubiquitination assays | PRKN/parkin activity and USP33 deubiquitination | Mitophagy regulation |
Measuring mitochondrial membrane potential
Potentiometric dyes such as TMRM or JC-1 are used to monitor loss of membrane potential in live cells. In situ cryo-ET can visualize depolarization and mitophagic engulfment at structural resolution. These methods define the occurrence of GO:0051882.
Assessing mitophagy flux
Depolarization-induced mitophagy can be measured by tracking mitochondrial protein degradation, colocalization with autophagosomes, and dependence on PINK1, PRKN, PHB2, RAB10, and LRRK2. USP33 deubiquitination assays can test reversibility of PRKN/parkin activation.
ATP and metabolic readouts
Mitochondrial depolarization often leads to ATP loss, which can be quantified by luminescence or Seahorse respirometry. In hepatotoxicity models, depolarization and repolarization kinetics are linked to ATP recovery.
Computational and electrophysiological modeling
Ventricular myocyte models can simulate how mitochondrial depolarization promotes calcium alternans, providing mechanistic insight into cardiac electrical instability. Electroporation parameters can be modeled against measured depolarization and ATP loss.
How CRISPR Can Be Used to Study GO:0051882 mitochondrial depolarization
Knockout
CRISPR knockout of PINK1, PRKN, PHB2, RAB10, LRRK2, or USP33 can be used to test their requirement for depolarization-induced mitophagy. Knockout cells are challenged with uncouplers and assessed for membrane potential, mitophagy flux, and ATP levels.
Point Mutation
Point-mutation knock-in of disease-associated variants such as LRRK2 mutations can reveal how specific residues impair mitochondrial RAB10 accumulation and depolarization-induced mitophagy. This approach links genotype to GO:0051882 phenotypes.
Knock-in
Tagged knock-in of PINK1, PRKN, or PHB2 with fluorescent or affinity tags enables real-time tracking of protein localization after depolarization. This is useful for cryo-ET and live-cell imaging.
Overexpression
Overexpression of PHB2, PRKN, or PINK1 can rescue or amplify depolarization-induced mitophagy, while overexpression of USP33 can antagonize it. Overexpression models help establish sufficiency in the pathway.
How EDITGENE Supports mitochondrial depolarization Research
Researchers studying mitochondrial depolarization-related genes often need to determine whether a candidate gene is causally involved in sensing, executing, or reversing loss of membrane potential. EDITGENE provides CRISPR-engineered cell models and screening services to test these hypotheses with publication-grade rigor.
Contact EDITGENE today to design your custom CRISPR model for mitochondrial depolarization research.
Frequently Asked Questions About mitochondrial depolarization
What is mitochondrial depolarization?
Mitochondrial depolarization (GO:0051882) is the process in which the potential difference across the mitochondrial membrane is reduced from its steady state level.
What genes are involved in mitochondrial depolarization?
Key genes include PINK1, PRKN, PHB2, RAB10, LRRK2, and USP33, which regulate sensing and mitophagy after depolarization.
How is mitochondrial depolarization measured?
It is commonly measured with potentiometric dyes such as TMRM or JC-1, and can be visualized structurally by in situ cryo-ET.
What happens after mitochondrial depolarization?
The mitochondrion may repolarize, be removed by PINK1-PRKN/Parkin-dependent mitophagy, or be released extracellularly as an alternative quality control route.
How does mitochondrial depolarization relate to Parkinson disease?
LRRK2 mutations impair depolarization-induced mitophagy through failed mitochondrial RAB10 accumulation, and PRKN/PINK1 are Parkinson disease genes.
Can mitochondrial depolarization be reversed?
Yes, in acetaminophen hepatotoxicity early depolarization can be followed by repolarization, indicating reversibility.
Does mitochondrial depolarization cause ATP loss?
Yes, high-frequency nanosecond and microsecond electroporation induce mitochondrial depolarization and ATP loss.
What is the role of PHB2 in mitochondrial depolarization?
PHB2 promotes PINK1-PRKN/Parkin-dependent mitophagy via the PARL-PGAM5-PINK1 axis.
How does USP33 affect mitophagy after depolarization?
USP33 deubiquitinates PRKN/parkin and antagonizes its role in mitophagy.
Can CRISPR be used to study mitochondrial depolarization?
Yes, CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression models can test gene function in GO:0051882.
Conclusion
Mitochondrial depolarization (GO:0051882) is a central biological process that links mitochondrial energetics to quality control, cell survival, and disease. Its molecular machinery includes PINK1, PRKN/Parkin, PHB2, RAB10, LRRK2, and USP33, which together determine whether a depolarized mitochondrion is repaired or removed. Dysregulation of this process is implicated in Parkinson disease, drug-induced liver injury, cardiac arrhythmia, and electroporation responses. CRISPR-based models and advanced imaging methods now make it possible to dissect the causal roles of individual genes in this pathway with high precision.
References
- 1. Rose K et al.. 2025. In situ cryo-ET visualization of mitochondrial depolarization and mitophagic engulfment.. Proc Natl Acad Sci U S A 122(31):e2511890122 PMID: 40743392
- 2. Wauters F et al.. 2020. LRRK2 mutations impair depolarization-induced mitophagy through inhibition of mitochondrial accumulation of RAB10.. Autophagy 16(2):203-222 PMID: 30945962
- 3. Yan C et al.. 2020. PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis.. Autophagy 16(3):419-434 PMID: 31177901
- 4. Choong CJ et al.. 2021. Alternative mitochondrial quality control mediated by extracellular release.. Autophagy 17(10):2962-2974 PMID: 33218272
- 5. Dunn KW et al.. 2020. Mitochondrial depolarization and repolarization in the early stages of acetaminophen hepatotoxicity in mice.. Toxicology 439:152464 PMID: 32315716
- 6. Malakauskaitė P et al.. 2024. Mitochondrial depolarization and ATP loss during high frequency nanosecond and microsecond electroporation.. Bioelectrochemistry 159:108742 PMID: 38776865
- 7. Pandey V et al.. 2021. Mitochondrial depolarization promotes calcium alternans: Mechanistic insights from a ventricular myocyte model.. PLoS Comput Biol 17(1):e1008624 PMID: 33493168
- 8. Niu K et al.. 2020. USP33 deubiquitinates PRKN/parkin and antagonizes its role in mitophagy.. Autophagy 16(4):724-734 PMID: 31432739
